Ben Ouyang
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
Papers in
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 15
-
- Immune cells in cancer 2
- Co-authors
- Warren C. W. Chan (15 shared papers)Benjamin R. Kingston (10 shared papers)Wilson Poon (6 shared papers)Jamie L. Y. Wu (4 shared papers)Yi-Nan Zhang (5 shared papers)Stefan Wilhelm (3 shared papers)Anton Zilman (4 shared papers)Zachary Pengju Lin (7 shared papers)
- Journals
- ACS Nano (5 papers)Nature Materials (3 papers)Acta Biomaterialia (2 papers)Nano Letters (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- CanadaUnited StatesPortugal
In The Last Decade
Ben Ouyang
23 papers receiving 4.8k citations
Ben Ouyang's Hit Papers
Peers
Comparison fields: 5 of 115
- Biomaterials 2.6k
- Biomedical Engineering 1.2k
- Drug Discovery 9
- Immunology 353
- Pharmaceutical Science 110
Countries citing papers authored by Ben Ouyang
This map shows the geographic impact of Ben Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ouyang more than expected).
Fields of papers citing papers by Ben Ouyang
This network shows the impact of papers produced by Ben Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ouyang. The network helps show where Ben Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The entry of nanoparticles into solid tumours Hit paper breakdown → | 2020 | 1453 |
| 2 | Mechanism of hard-nanomaterial clearance by the liver Hit paper breakdown → | 2016 | 867 |
| 3 | Elimination Pathways of Nanoparticles Hit paper breakdown → | 2019 | 480 |
| 4 | A framework for designing delivery systems Hit paper breakdown → | 2020 | 461 |
| 5 | The dose threshold for nanoparticle tumour delivery Hit paper breakdown → | 2020 | 455 |
| 6 | 2017 | 265 | |
| 7 | 2016 | 203 | |
| 8 | 2019 | 173 | |
| 9 | 2021 | 114 | |
| 10 | 2012 | 100 | |
| 11 | 2022 | 92 | |
| 12 | 2019 | 50 | |
| 13 | 2020 | 37 | |
| 14 | 2013 | 34 | |
| 15 | 2016 | 28 | |
| 16 | 2020 | 24 | |
| 17 | 2015 | 22 | |
| 18 | 2013 | 17 | |
| 19 | 2016 | 13 | |
| 20 | 2022 | 11 |
About Ben Ouyang
Ben Ouyang is a scholar working on Biomaterials, Immunology, Oncology, Surfaces, Coatings and Films and Hepatology, having authored 24 papers that have together received 4.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers), Nanoplatforms for cancer theranostics (2 papers), Polymer Surface Interaction Studies (1 paper), Liver physiology and pathology (1 paper), Health and Medical Research Impacts (1 paper) and Surgical Sutures and Adhesives (1 paper). The work is most often cited by research in Biomaterials (2.6k citations), Biomedical Engineering (1.2k citations), Drug Discovery (9 citations), Immunology (353 citations) and Pharmaceutical Science (110 citations). Ben Ouyang has collaborated with scholars based in Canada, United States and Portugal. Frequent co-authors include Warren C. W. Chan, Benjamin R. Kingston, Wilson Poon, Jamie L. Y. Wu, Yi-Nan Zhang, Stefan Wilhelm, Anton Zilman, Zachary Pengju Lin, Presley MacMillan and Abdullah M. Syed. Their work appears in journals such as ACS Nano, Nature Materials, Acta Biomaterialia, Nano Letters and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.